Anna Członkowska Selected Research

Hepatolenticular Degeneration (Wilson's Disease)

9/2022	Liver injury in Wilson's disease: An immunohistochemical study.
7/2022	Brain magnetic resonance imaging and severity of neurological disease in Wilson's disease - the neuroradiological correlations.
6/2022	Sleep disturbances in newly diagnosed treatment-naïve patients with Wilson's disease.
4/2022	Liver transplantation as a treatment for Wilson's disease with neurological presentation: a systematic literature review.
1/2022	Serum Neurofilament Light Chain as a Biomarker of Brain Injury in Wilson's Disease: Clinical and Neuroradiological Correlations.
12/2021	Autonomic nervous system dysfunction in Wilson's disease - A systematic literature review.
1/2021	D-penicillamine-induced lupus erythematosus as an adverse reaction of treatment of Wilson's Disease.
1/2021	Evaluation of liver fibrosis in patients with Wilson's disease.
9/2020	Transcranial sonography changes in heterozygotic carriers of the ATP7B gene.
1/2020	Gastropathy in patients with Wilson disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Członkowska Research Topics

Disease

55	Hepatolenticular Degeneration (Wilson's Disease) 09/2022 - 02/2006
42	Stroke (Strokes) 01/2022 - 04/2002
14	Ischemic Stroke 01/2020 - 01/2005
10	Inborn Genetic Diseases (Disease, Hereditary) 07/2022 - 03/2013
8	Parkinson Disease (Parkinson's Disease) 08/2014 - 08/2002
6	Multiple Sclerosis 03/2017 - 10/2003
5	Brain Injuries (Brain Injury) 01/2022 - 01/2007
5	Neurologic Manifestations (Neurological Manifestations) 12/2021 - 08/2015
5	Cognitive Dysfunction 01/2019 - 10/2003
5	Atrial Fibrillation 01/2014 - 10/2002
4	Liver Diseases (Liver Disease) 04/2019 - 01/2016
4	Aphasia (Dysphasia) 05/2013 - 09/2009
3	Hypertension (High Blood Pressure) 01/2019 - 03/2008
2	Paresis (Hemiparesis) 11/2020 - 11/2012
2	Fibrosis (Cirrhosis) 01/2019 - 01/2010
2	Seizures (Absence Seizure) 06/2015 - 10/2010
2	Inflammation (Inflammations) 04/2006 - 08/2002
2	Relapsing-Remitting Multiple Sclerosis 11/2003 - 11/2003
1	Nervous System Trauma 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Infections 01/2020
1	Chronic Disease (Chronic Diseases) 11/2019
1	Demyelinating Diseases (Demyelinating Disease) 04/2019
1	Cataract (Cataracts) 04/2019
1	Gliosis 04/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Liver Failure 07/2018
1	Perceptual Disorders (Hemispatial Neglect) 12/2016
1	CADASIL 07/2016
1	Brain Neoplasms (Brain Tumor) 06/2015
1	Vertigo (Positional Vertigo) 06/2015
1	Metabolic Brain Diseases (Encephalopathy, Metabolic) 04/2015

Drug/Important Bio-Agent (IBA)

48	CopperIBA 09/2022 - 02/2006
8	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 11/2006
5	Penicillamine (Cuprimine)FDA Link 01/2021 - 02/2014
5	Antihypertensive Agents (Antihypertensives)IBA 01/2014 - 03/2008
4	IronIBA 04/2019 - 05/2012
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2004
4	AnticoagulantsIBA 11/2013 - 05/2003
4	salicylhydroxamic acid (SHAM)IBA 05/2013 - 01/2012
4	CytokinesIBA 01/2007 - 08/2002
3	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2020 - 09/2006
3	Pharmaceutical PreparationsIBA 11/2019 - 05/2010
3	ZincIBA 01/2017 - 01/2014
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 08/2014 - 09/2004
3	Messenger RNA (mRNA)IBA 08/2014 - 01/2003
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014 - 11/2013
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2013 - 10/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013 - 08/2002
2	Zinc Sulfate FDA Link 01/2020 - 08/2015
2	Copper Transport ProteinsIBA 01/2019 - 10/2018
2	Thrombin FDA Link 10/2017 - 01/2017
2	AntioxidantsIBA 01/2015 - 02/2014
2	Interleukin-10 (Interleukin 10)IBA 08/2014 - 01/2013
2	Adenosine Triphosphatases (ATPase)IBA 01/2014 - 05/2009
2	MetalsIBA 01/2014 - 12/2013
2	Apolipoproteins E (ApoE)IBA 01/2007 - 01/2005
2	AntibodiesIBA 01/2007 - 04/2002
2	CholesterolIBA 11/2006 - 01/2005
2	Estrogens (Estrogen)FDA Link 04/2006 - 10/2003
2	Interferon beta-1a FDA Link 11/2003 - 11/2003
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	CollagenIBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2020
1	UreaseIBA 01/2020
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Contraceptive Agents (Contraceptives)IBA 01/2019
1	Polycomb Repressive Complex 1IBA 01/2019
1	hydrogen sulfite (bisulfite)IBA 01/2019
1	Investigational DrugsIBA 06/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 03/2017
1	Chelating AgentsIBA 01/2017
1	FibrinIBA 01/2017
1	SaltsIBA 01/2017
1	Notch3 ReceptorIBA 07/2016
1	Retinaldehyde (Retinal)IBA 04/2016
1	Copper-Transporting ATPasesIBA 01/2016
1	Dopamine AntagonistsIBA 08/2015
1	ElectrolytesIBA 06/2015
1	TeaIBA 01/2015

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2006
6	Transcranial Magnetic Stimulation 11/2020 - 09/2009
4	Drug Therapy (Chemotherapy) 01/2016 - 06/2009
4	Neurological Rehabilitation 01/2014 - 02/2009
3	Aftercare (After-Treatment) 01/2017 - 11/2012
3	Transcranial Direct Current Stimulation 05/2014 - 03/2010
3	Cognitive Training 05/2014 - 01/2006
3	Secondary Prevention 01/2014 - 03/2008
3	Language Therapy (Language Training) 05/2013 - 01/2012
3	Speech Therapy (Therapy, Speech) 05/2011 - 01/2006
3	Thrombolytic Therapy 04/2011 - 11/2006
2	Liver Transplantation 04/2022 - 04/2008
2	Time-to-Treatment 06/2015 - 01/2012
2	Diagnostic Equipment 03/2007 - 09/2004
2	Estrogen Replacement Therapy 10/2003 - 01/2003
1	Punctures 09/2017
1	Thrombectomy 09/2017
1	Transcutaneous Electric Nerve Stimulation (TENS) 12/2016